SPDL1 and COVID-19: We previously proposed sPD-L1 as a valuable prognosis biomarker for COVID-19, having found that high levels of sPD-L1 correlated with low lymphocyte counts and high CRP levels and were also associated with longer hospital length of stay (LOS) and death.